Since the first introduction of single mutational markers, among the others BRAF and small gene panels, the use of expanded genomic panels, multi-gene classifiers, and use of other molecular markers have highlighted the possibility of a better diagnostic accuracy, although most of these approaches still have not reached the highest possible accuracy in the detection of all main types of thyroid cancer. The gene discussed is BRAF; the disease is thyroid cancer.